Who Paid My Doc
Mirasol Pathogen Reduction Technology System
Device Pathogen reduction
General payments
$775,712
Research payments
$4,444,033
Through program year 2023, $775,712 in general payments and $4,444,033 in research payments were reported against Mirasol Pathogen Reduction Technology System (Pathogen reduction).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
8 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2023 | General | $47,744 | 12 |
| 2022 | General | $54,394 | 13 |
| 2021 | General | $36,828 | 13 |
| 2021 | Research | $349,608 | 5 |
| 2020 | General | $240,000 | 119 |
| 2020 | Research | $1,918,463 | 86 |
| 2019 | General | $396,747 | 112 |
| 2019 | Research | $2,175,963 | 91 |
Breakdown
Each share is of general payments naming this product in 2023.
Each share is of general payments naming this product to practitioners with a specialty in 2023. Each practitioner is counted under their primary specialty.
Each share is of general payments naming this product in 2023 where a state was reported.
Records
269 general · 182 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.